Literature DB >> 10220039

The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity.

J B Aggen1, J M Humphrey, C M Gauss, H B Huang, A C Nairn, A R Chamberlin.   

Abstract

Based on the results from previously reported molecular modeling analyses of the interactions between the inhibitor microcystin and the serine-threonine protein phosphatases 1 and 2A, we have designed analogues of microcystin LA with structural modifications intended to impart PP1 selectivity. The synthesis of several first generation analogues followed by inhibition assays revealed that all three are PP1-selective, as predicted. Although the observed selectivities are modest, one of the designed analogues is more selective for PP1 than any known small molecule inhibitor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220039     DOI: 10.1016/s0968-0896(98)00254-5

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Development of stable phosphohistidine analogues.

Authors:  Jung-Min Kee; Bryeanna Villani; Laura R Carpenter; Tom W Muir
Journal:  J Am Chem Soc       Date:  2010-10-20       Impact factor: 15.419

Review 2.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

3.  Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.

Authors:  Manoj P Samant; Jozsef Gulyas; Doley J Hong; Glenn Croston; Catherine Rivier; Jean Rivier
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

4.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 5.  Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Authors:  Ioannis Sainis; Demosthenes Fokas; Katerina Vareli; Andreas G Tzakos; Valentinos Kounnis; Evangelos Briasoulis
Journal:  Mar Drugs       Date:  2010-03-15       Impact factor: 5.118

6.  Synthesis of Highly Selective Submicromolar Microcystin-Based Inhibitors of Protein Phosphatase (PP)2A over PP1.

Authors:  Miriam Fontanillo; Ivan Zemskov; Maximilian Häfner; Ulrike Uhrig; Francesca Salvi; Bernd Simon; Valentin Wittmann; Maja Köhn
Journal:  Angew Chem Int Ed Engl       Date:  2016-10-10       Impact factor: 15.336

7.  Molecular coordination of Staphylococcus aureus cell division.

Authors:  Victoria A Lund; Katarzyna Wacnik; Robert D Turner; Bryony E Cotterell; Christa G Walther; Samuel J Fenn; Fabian Grein; Adam Jm Wollman; Mark C Leake; Nicolas Olivier; Ashley Cadby; Stéphane Mesnage; Simon Jones; Simon J Foster
Journal:  Elife       Date:  2018-02-21       Impact factor: 8.140

Review 8.  Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases.

Authors:  Silvio Weber; Stefanie Meyer-Roxlau; Michael Wagner; Dobromir Dobrev; Ali El-Armouche
Journal:  Front Pharmacol       Date:  2015-11-13       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.